Medical marijuana use in clinical trials could soon be legal in Australia
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Australia has legalised the growth of marijuana for use in research, in the first step towards potentially legalising the drug for patients dealing with painful conditions.
While the drug is currently illegal in Australia, two states?? Are discussing whether to allow people to use it therapeutically.
The bill which the Liberal Party introduced to the country's parliament will change the Narcotics Drugs Act 1967. It looks likely to become law, as the main opposition party has offered its support. It is expected to come into play in March, Quartz reported.
The result will be the creation of a national licensing scheme and permits to supply medical cannabis to patients with painful and chronic conditions on clinical trials.
Health Minister Sussan Ley told Parliament said that the government wanted to enable “Australians suffering from severe conditions” to use “the most effective medical treatments” including marijuana.
“Allowing controlled cultivation locally will provide the critical missing piece for a sustainable legal supply of safe medicinal cannabis products for Australian patients in the future,” he said prior to appearing in parliament.
The government, which operates in a region with some of the strictest drug policies in the world, stressed that the amendment would not break Australia’s international obligations to make sure that the drug is only produced and sold for medical and scientific purposes.
Currently, Australian manufacturers, researchers and patients on clinical trials have had to use international supplies of legal medicinal marijuana – which is made difficult by the costs and export restrictions.
However, it would still be illegal for patients outside of clinical trials and the general public to use the drug if the law passes.
MMJ PhytoTech Ltd became Australia's first listed medicinal marijuana company following an initial public offering last year that was three times oversubscribed.
“The market for medicinal cannabis in Australia is substantial. The number of patients that could be targeted could be people with epilepsy, Multiple sclerosis, while there is the other spectrum of people with chronic pain,” said Gaelan Bloomfield, manager at MMJ PhytoTech Ltd.
Additional reporting by Reuters
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments